[
    [
        {
            "time": "",
            "original_text": "康龙化成现2笔大宗交易 ，共成交8,960.00万元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": -0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成现2笔大宗交易 ，共成交8,960.00万元",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(03759)：君联闻达及君联茂林累计完成减持930.57万股A股股份 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "君联闻达",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成(03759)：君联闻达及君联茂林累计完成减持930.57万股A股股份 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759.SZ)遭主要股东君联闻达及其一致行动人君联茂林累计减持930.57万股 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "君联闻达",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成(300759.SZ)遭主要股东君联闻达及其一致行动人君联茂林累计减持930.57万股 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(300759.SZ)：君联闻达和君联茂林再减持1.17%股份 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "君联闻达",
                    "君联茂林",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成(300759.SZ)：君联闻达和君联茂林再减持1.17%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成持股5%以上股东累计减持930.57万股 占总1.17% 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "持股5%",
                    "股东",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成持股5%以上股东累计减持930.57万股 占总1.17% 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成：股东及一致行动人累计减持达1.17%公司股份 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "股东",
                    "一致行动人",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成：股东及一致行动人累计减持达1.17%公司股份 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成：持股5%以上股东君联闻达及其一致行动人减持股份占公司股本总数的比例为1.17% 减持股份",
            "features": {
                "keywords": [
                    "康龙化成",
                    "持股5%",
                    "君联闻达",
                    "一致行动人",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康龙化成：持股5%以上股东君联闻达及其一致行动人减持股份占公司股本总数的比例为1.17% 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫情影响逐渐消退，关注高成长龙头+细分冠军 -- 医药生物上市公司2020年三季报小结",
            "features": {
                "keywords": [
                    "疫情",
                    "影响",
                    "消退",
                    "高成长",
                    "龙头",
                    "细分冠军",
                    "医药生物",
                    "三季报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫情影响逐渐消退，关注高成长龙头+细分冠军 -- 医药生物上市公司2020年三季报小结",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 2,
                "Headline_Structure": 5,
                "Source_Recency": 1
            }
        },
        {
            "time": "",
            "original_text": "【浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
            "features": {
                "keywords": [
                    "浙商医药",
                    "三季报",
                    "创新药",
                    "研发",
                    "高景气",
                    "CDMO",
                    "业绩加速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 5,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 2,
                "Headline_Structure": 6,
                "Source_Recency": 1
            }
        }
    ]
]